Зарегистрируйтесь, чтобы создавать уведомления по инструментам,
экономическим событиям и аналитике.
Бесплатная регистрация У вас уже есть учетная запись? Вход
Котировки
Все типы инструментов
- Все типы инструментов
- Индексы
- Акции
- ETF
- Фонды
- Товары
- Валюты
- Крипто
- Облигации
- Сертификаты
Попробуйте другой запрос
🥇 Первое правило инвестирования? Не упускайте возможности сэкономить! Скидка до 55% на InvestingPro до ЧЕРНОЙ ПЯТНИЦЫ
Купить со скидкой
Allianz Biotechnologie A Eur (0P00000CML)
Добавить/Удалить из списка наблюдения
Добавить в список наблюдения
225,830
+2,170
+0,97%
08/11 - Закрыт. Цена в EUR
Вид:
Фонд
Рынок:
Германия
Эмитент:
Allianz Global Investors GmbH
ISIN:
DE0008481862
Класс активов:
Акции
- Рейтинг Morningstar:
- Итого активов: 305,44M
Allianz Biotechnologie A EUR
225,830
+2,170
+0,97%
- Обзор
- Профиль
- Прошлые данные
- Активы
Обзор 0P00000CML
На этой странице представлен подробный профиль Allianz Biotechnologie A Eur. Узнайте о руководителях, совокупных активах, стратегии инвестиций и контактной информации 0P00000CML, а также получите ряд других сведений.
Контактная информация
Адрес
L-2633 Senningerberg
Frankfurt am Main, 60323
Germany
Frankfurt am Main, 60323
Germany
Телефон
+49 (0) 69 2443-1140
Факс
Frankfurt am Main
Веб-сайт
www.allianzglobalinvestors.de
Руководители
| Название | Заголовок | Год | До |
|---|---|---|---|
| Peter Pirsch | Senior Portfolio Manager | 2019 | Сейчас |
| Биография | Mr. Pirsch is a senior portfolio manager, a senior analyst and a director with Allianz Global Investors, which he joined in 2018. He has management and research responsibilities for the Health Care team. Mr. Pirsch has 20 years of investment-industry experience. He previously worked at Aptigon Capital, Visium Asset Management, Surveyor Capital, Fred Alger Management and C.R. Bard. Before that, Mr. Pirsch was an associate director at UBS Investment Bank and an analyst at Wells Fargo. He has a B.A. in economics and international relations from Bucknell University, and an M.B.A. with a certificate in health sector management from Duke University, Fuqua School of Business. Mr. Pirsch is a CFA charterholder. | ||
| Christopher Chin | - | 2019 | Сейчас |
| Kimberlee W. Millar | Vice President | 2018 | 2021 |
| Биография | Ms. Millar is a portfolio manager, analyst and director with Allianz Global Investors, which she joined in 2005. As a generalist for the Disciplined Equities group, her primary responsibility is conducting company research; she also helps improve the group’s overall investment processes and contributes toward its portfolio-management efforts. Ms. Millar has 23 years of investment industry experience. She previously worked as an assistant economist at the Investment Company Institute in Washington, D.C., producing mutual-fund-industry research for investment-management firms’ research and marketing departments. Before that, Ms. Millar worked at Heiden Associates Inc., an economic consulting firm in Washington, D.C. She has a B.A. in economics from the University of Calgary, Canada, and an M.A. in economics from Queen’s University, Canada. Ms. Millar is a CFA charterholder and a member of the CFA Institute. | ||
| Hugo Ong | - | 2018 | 2021 |
| Christopher Chin | - | 2018 | 2019 |
| Peter Pirsch | Senior Portfolio Manager | 2018 | 2019 |
| Биография | Mr. Pirsch is a senior portfolio manager, a senior analyst and a director with Allianz Global Investors, which he joined in 2018. He has management and research responsibilities for the Health Care team. Mr. Pirsch has 20 years of investment-industry experience. He previously worked at Aptigon Capital, Visium Asset Management, Surveyor Capital, Fred Alger Management and C.R. Bard. Before that, Mr. Pirsch was an associate director at UBS Investment Bank and an analyst at Wells Fargo. He has a B.A. in economics and international relations from Bucknell University, and an M.B.A. with a certificate in health sector management from Duke University, Fuqua School of Business. Mr. Pirsch is a CFA charterholder. | ||
| John R. Schroer | Portfolio Manager | 2014 | 2018 |
| Биография | Mr. Schroer, CFA, is a portfolio manager and a director with Allianz Global Investors, which he joined in 2014. He is the sector head of the Health Care team. He was previously the president of Schroer Capital, L.P.; an equity analyst with HealthCor Management, L.P.; a managing member and portfolio manager for ITROS Capital Management, LLC; a global partner, senior vice president, and portfolio manager for INVESCO; and an analyst for Trust Company of the West. Mr. Schroer has a B.S. in history and international relations and an M.B.A. in finance from the University of Wisconsin. | ||
| Paul A. Wagner | Senior Research Analyst | 2012 | 2014 |
| Биография | Mr. Wagner, CFA, is a portfolio manager, a senior research analyst and a director with Allianz Global Investors, which he joined in 2006. He has biotechnology responsibilities for the US Health Care team and has 14 years of investment-industry experience. Mr. Wagner previously worked at PDL BioPharma in corporate and business development, and was a vice president and senior equity-research analyst in the biotechnology sector at Lehman Brothers. He has a B.S. in chemistry from the University of Wisconsin and a Ph.D. in chemistry from the California Institute of Technology. | ||
| Nicole Papassavvas | - | 2008 | 2012 |
| Javier Latorre | - | 2007 | 2012 |
Ваш комментарий по инструменту: Allianz Biotechnologie A Eur
Вы действительно хотите удалить этот график?
Удалить Отмена
Заменить данный график на новый?
Заменить Отмена
Правила дискуссии
Добавить график к комментарию
Подтвердить блокировку
Вы уверены, что хотите заблокировать пользователя %USER_NAME%?
После этого вы и %USER_NAME% не сможете видеть комментарии друг друга на Investing.com.
%USER_NAME% добавлен в ваш черный список
Вы только что разблокировали этого участника. Повторно заблокировать этого участника можно только через 48 часов.
Пожаловаться на комментарий
Я считаю, что данный комментарий:
Комментарий отмечен
Спасибо!
Ваша жалоба отправлена модераторам.